While pharma services is a hot area for PE, valuation uncertainty is putting a wrench in the health care dealmaking gears
Aaron Weitzman is a Health Tech Deals Reporter for Axios Pro. He covers the latest developments and trends in the health technology industry, with a focus on mergers and acquisitions, digital health innovations, and the impact of technology on healthcare. Aaron's reporting provides valuable insights into the intersection of technology and healthcare, helping readers stay informed about the rapidly evolving landscape of health tech.